Holen Sie sich die Stockscreener-App
419.26
2.18%
-9.36
Handel nachbörslich:
419.26
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$428.62
Offen:
$429.3
24-Stunden-Volumen:
788.19K
Relative Volume:
1.26
Marktkapitalisierung:
$34.33B
Einnahmen:
$3.84B
Nettoeinkommen (Verlust:
$866.24M
KGV:
40.43
EPS:
10.37
Netto-Cashflow:
$792.60M
1W Leistung:
+0.29%
1M Leistung:
-1.83%
6M Leistung:
-15.55%
1J Leistung:
-18.67%
1-Tages-Spanne:
$418.66
$432.95
1-Wochen-Bereich:
$412.68
$432.95
52-Wochen-Spanne:
$398.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
419.26 | 34.33B | 3.84B | 866.24M | 792.60M | 10.37 |
|
TMO
Thermo Fisher Scientific Inc
|
559.65 | 214.07B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
238.36 | 172.16B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
147.36 | 42.09B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.36 | 35.82B | 15.32B | 1.41B | 1.96B | 7.62 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Short Interest in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Increases By 7.1% - MarketBeat
Seilern Investment Management Ltd Purchases New Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing? - Yahoo Finance
Sax Wealth Advisors LLC Purchases 617 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
RDA Financial Network Grows Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Carderock Capital Management Inc. Has $5.69 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Avanza Fonder AB Invests $2.69 Million in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Gateway Investment Advisers LLC Purchases 1,274 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Oak Thistle LLC Makes New $426,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories Sets Q4 and Full Year 2024 Earnings Release Date for February 3 - StockTitan
Claro Advisors LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market - MarketWatch
IDEXX Stock Suffers Due to Macroeconomic Issues and FX Woes - Yahoo Finance
Assenagon Asset Management S.A. Buys 316,048 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
CHICAGO TRUST Co NA Decreases Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Declining Stock and Solid Fundamentals: Is The Market Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX)? - Yahoo Finance
International Assets Investment Management LLC Sells 527,447 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know - Nasdaq
IDEXX Laboratories' Quarterly Earnings Preview: What You Need To Know - Barchart
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Westwind Capital Raises Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Bath Savings Trust Co Sells 3,308 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Insight Wealth Strategies LLC Has $4.17 Million Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by JPMorgan Chase & Co. - MarketBeat
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance
IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly - Simply Wall St
IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market - MarketWatch
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
IDEXX Laboratories Inc. stock rises Monday, still underperforms market - MarketWatch
Is IDEXX Laboratories Stock Underperforming the S&P 500? - MSN
IDEXX Laboratories Inc. stock rises Friday, still underperforms market - MarketWatch
Jim Cramer on IDEXX Laboratories (IDXX): Is This Pet Stock Poised for a Comeback? - Insider Monkey
IDEXX Laboratories (NASDAQ:IDXX) Issues FY 2024 Earnings Guidance - MarketBeat
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX - The Manila Times
IDEXX Laboratories' (NASDAQ:IDXX) earnings growth rate lags the 9.3% CAGR delivered to shareholders - Yahoo Finance
IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
IDEXX Laboratories' SWOT analysis: veterinary diagnostics leader faces market headwinds - Investing.com India
Wilmington Savings Fund Society FSB Has $999,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Franklin Resources Inc. Boosts Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):